CrushSCI.com
109.9Average days
99Median days
43Fastest days
210Longest days
3322025 publications

Paper Review Records

All Paper Review Records

25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

72 days

Transporter‐Associated Therapeutic Efficacy of an SMVT ‐Targeted Boron Carrier in Boron Neutron Capture Therapy

Authors
Kenichiro Eza; Kohei Tsujino; Rina Shidoh‐Kazuki; Yoshiki Fujikawa; Hideki Kashiwagi; Gen Futamura; Ryo Hiramatsu; Toshihiro Takami; Masahiko Wanibuchi; Naonori Hu; Hiroki Tanaka; Minoru Suzuki; Kai Nishimura; Shota Tanaka; Hiroyuki Nakamura; Shinji KawabataShow moreShow less
Affiliations
1. Department of Neurosurgery Osaka Medical and Pharmaceutical University Takatsuki Osaka Japan; 2. Kansai BNCT Medical Center Osaka Medical and Pharmaceutical University Takatsuki Osaka Japan; 3. Institute for Integrated Radiation and Nuclear Science Kyoto University Kumatori, Sennan Osaka Japan; 4. School of Life Science and Technology Institute of Science Tokyo Yokohama Kanagawa Japan; 5. Laboratory of BNCT Advancement in Neuro‐Oncology Osaka Medical and Pharmaceutical University Takatsuki Osaka JapanShow moreShow less
Source PDF DOI Publisher page
162 days

Ketogenic Diet and β‐Hydroxybutyrate Suppress Bladder Cancer Growth and Enhance Anti‐ PD ‐ L1 Immunotherapy Efficacy

Authors
Yuan Zeng; Gangli Gu; Lin Yang; Bohao Fan; Haochen Cui; Lei Yan; Zhao LiuShow moreShow less
Affiliations
1. Department of Urology, Qilu Hospital, Cheeloo College of Medicine Shandong University Jinan China; 2. Department of Anesthesiology Xiongan Xuanwu Hospital Xiongan ChinaShow moreShow less
Source PDF DOI Publisher page
158 days

Bile‐Derived Exosomal miR ‐196a/‐196b as Diagnostic Biomarkers Associated With Tumor Progression in Biliary Tract Cancer

Authors
Naotaka Kugiyama; Katsuya Nagaoka; Takehisa Watanabe; Michihiro Yoshida; Tadashi Toyohara; Cheng Pan; Kenyu Hashimoto; Fumiya Otsuka; Shinya Ushijima; Yukiko Uramoto; Hajime Iwasaki; Motohiro Yoshinari; Shunpei Hashigo; Kazuki Hayashi; Itaru Naitoh; Fumihiro Okumura; Hiromu Kondo; Kaiki Anbe; Hiromitsu Hayashi; Yoshihiro Komohara; Yasuhito TanakaShow moreShow less
Affiliations
1. Department of Gastroenterology and Hepatology, Faculty of Life Sciences Kumamoto University Kumamoto Japan; 2. Department of Gastroenterology and Metabolism Nagoya City University Graduate School of Medical Sciences Nagoya Japan; 3. Department of Cell Pathology, Faculty of Life Sciences Kumamoto University Kumamoto Japan; 4. Department of Clinical Investigation Kumamoto University Hospital Kumamoto Japan; 5. Department of Gastroenterology Kumamoto City Hospital Kumamoto Japan; 6. Department of Gastroenterology Nagoya City University East Medical Center Nagoya Japan; 7. Department of Gastroenterology Nagoya City University Midori Municipal Hospital Nagoya Japan; 8. Department of Gastroenterology Gifu Prefectural Tajimi Hospital Tajimi Japan; 9. Department of Gastroenterology Nagoya City University West Medical Center Nagoya Japan; 10. Department of Gastroenterology Toyokawa Municipal Hospital Toyokawa Japan; 11. Department of Gastroenterological Surgery, Faculty of Life Sciences Kumamoto University Kumamoto JapanShow moreShow less
Source PDF DOI Publisher page
131 days

RASD 2 Drives Renal Clear Cell Carcinoma Progression via RAF 1 (Ser338) Phosphorylation

Authors
Jingxuan Yu; Gang Yu; Yuan Liu; Yu Zhou; Wei Liu; Lin Wang; Lide Liu; Yan Liu; Tiejun Pan; Zhenyu Liu; Lei GaoShow moreShow less
Affiliations
1. Department of Urology, Postgraduate Union Training Base of General Hospital of Central Theater Command, School of Medicine Wuhan University of Science and Technology Wuhan Hubei China; 2. Department of Urology General Hospital of Central Theater Command of Chinese People's Liberation Army Wuhan Hubei China; 3. Xianning Central Hospital The First Affiliated Hospital of Hubei University of Science and Technology Xianning Hubei China; 4. Southwest Hospital, Army Medical University (Third Military Medical University) Chongqing China; 5. General Hospital of Central Theater Command and Hubei Key Laboratory of Central Nervous System Tumor and Intervention Wuhan Hubei China; 6. School of Clinical Medicine Hubei University of Chinese Medicine Wuhan Hubei ChinaShow moreShow less
Source PDF DOI Publisher page
95 days

Afatinib Versus Osimertinib for Non‐Small Cell Lung Cancer With Uncommon EGFR Mutations: Real‐World Outcomes

Authors
Yutaro Nagano; Hiroshi Yokouchi; Ryota Saito; Osamu Honjo; Toshiyuki Sumi; Takayuki Kaburagi; Kenichiro Ito; Yasuyuki Ikezawa; Keiki Yokoo; Hajime Kikuchi; Sayaka Kudo; Masami Yamazoe; Ryota Shigaki; Keita Tagami; Toshiyuki Tenma; Tatsuru Ishikawa; Mamoru Takahashi; Takaaki Sasaki; Hajime Asahina; Shiro Hinotsu; Hirofumi Chiba; Satoshi OizumiShow moreShow less
Affiliations
1. Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine Sapporo Japan; 2. Department of Respiratory Medicine NHO Hokkaido Cancer Center Sapporo Japan; 3. Department of Respiratory Medicine Yamanashi Prefectural Central Hospital Yamanashi Japan; 4. Department of Respiratory Medicine Sapporo Minami‐Sanjo Hospital Sapporo Japan; 5. Department of Respiratory Medicine Hakodate Goryoukaku Hospital Hakodate Japan; 6. Department of Respiratory Medicine Ibaraki Prefectural Central Hospital Kasama Japan; 7. Department of Respiratory Medicine KKR Sapporo Medical Center Sapporo Japan; 8. Department of Respiratory Medicine Hokkaido University Hospital Sapporo Japan; 9. Department of Respiratory Medicine Teine Keijinkai Hospital Sapporo Japan; 10. Department of Respiratory Medicine Obihiro Kosei Hospital Obihiro Japan; 11. Department of Respiratory Medicine Kushiro City General Hospital Kushiro Japan; 12. Department of Respiratory Medicine Hakodate Municipal Hospital Hakodate Japan; 13. Department of Respiratory Medicine Hokkaido Prefectural Kitami Hospital Kitami Japan; 14. Department of Respiratory Medicine Nayoro City General Hospital Nayoro Japan; 15. Department of Internal Medicine, Division of Respiratory Medicine and Neurology Asahikawa Medical University Asahikawa Japan; 16. Department of Biostatistics and Data Management Sapporo Medical University School of Medicine Sapporo JapanShow moreShow less
Source PDF DOI Publisher page
50 days

Interpreting Early‐Onset Colorectal Cancer in Japan: A Descriptive Epidemiologic Review Using Public Summary Statistics

Authors
Keitaro Matsuo; Hidemi ItoShow moreShow less
Affiliations
1. Division of Cancer Epidemiology and Prevention Aichi Cancer Center Nagoya Aichi Japan; 2. Division of Cancer Epidemiology Nagoya University Graduate School of Medicine Nagoya Aichi Japan; 3. Division of Cancer Information and Control Aichi Cancer Center Nagoya Aichi Japan; 4. Division of Descriptive Cancer Epidemiology Nagoya University Graduate School of Medicine Nagoya Aichi JapanShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.